Drug Profile
Human telomerase reverse transcriptase cancer vaccine - Merck & Co/Fresh Tracks Therapeutics
Alternative Names: hTERT cancer vaccine - Merck & Co/Fresh Tracks TherapeuticsLatest Information Update: 25 Sep 2023
Price :
$50
*
At a glance
- Originator Merck & Co; Vical
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer